Dynamic networking and pitch sessions at ICCS 2019
Oslo Cancer Cluster and its international partners organised the International Cancer Cluster Showcase (ICCS) on 3 June in Philadelphia, kickstarting this year’s BIO International Convention.
The aim of this annual event is to showcase cutting edge oncology research and development activities performed in start-ups and biotechs from Oslo Cancer Cluster and its international partners from North America and Europe.
This year’s meeting offered a compact program including company presentations, engaging poster sessions and lively networking among representatives of the international oncology community.
Jutta Heix, Head of International Affairs at Oslo Cancer Cluster, and main organizer of the event:
“Building on the first meeting at the Whitehead Institute in Cambridge in 2012, ICCS was established as a successful format to expose and connect emerging oncology companies to executives of the global oncology community attending the BIO International Convention.
“Via collaboration with partners from North American and European innovation hubs, we gather a strong group of exciting new companies and attract more than 200 participants.”
Jan Alfheim, CEO of Oncoinvent, another member of Oslo Cancer Cluster also held a presentation.
Among this year’s presenters were our members OncoInvent and Vaccibody. The dynamic pitch session featured 20 companies from 9 countries advancing a variety of innovative oncology technologies and assets in preclinical and clinical development.
“ICCS was a great opportunity to present Vaccibody and our recent progress towards a relevant international audience. It triggered new contacts and stimulated good discussions following the presentation.”
Martin Bonde, CEO of Vaccibody
Commenting on the highlights, Heix said:
“The National Institutes of Health / National Cancer Institute (NCI) participated for the 2nd time. Michael Salgaller, Supervisory Specialist Technology Transfer Center presented the partnering opportunities and benefits the NCI offers to outside parties from academia and industry.
“Our sponsors Precision for Medicine, Takeda Oncology and Boehringer Ingelheim enriched the program by short presentations and active discussions during the humming poster and networking sessions.”
The event was sponsored by:
The event was organised by:
